Balversa 4 MG
Ended Awarded
- Contract number
- 36C24525N0814
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $18,804
Award facts
- Contract value 100% obligated
- $18,803.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., a pharmaceutical manufacturer of biologic therapies. The contract is a delivery order valued at $18,803.91 for the oncology medication BALVERSA 4 MG, awarded by the U.S. Department of Veterans Affairs (VA) through the Veterans Health Administration. The contract is a firm fixed price delivery order with no set-aside designation, issued against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). This contract is part of a larger $15 million single-award Blanket Purchase Agreement (BPA) held by Janssen Biotech for BALVERSA and CARVYKTI, enabling the VA to efficiently procure these specialized oncology medications to support healthcare services for veterans nationwide.
Quick answers
Who was awarded contract 36C24525N0814?
36C24525N0814 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on July 16, 2025.
How much is contract 36C24525N0814 worth?
The government has obligated $18,804 on 36C24525N0814.
Is contract 36C24525N0814 an order under another contract?
Yes. 36C24525N0814 is a delivery order under 36F79724D0176, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0814 competed?
The extent of competition for 36C24525N0814 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award